News & Presentations

News Releases

Tarsus Launches “Look at the Lids” Campaign to Encourage Eye Care Professionals to Identify and Diagnose Demodex Blepharitis
Sep 29, 2022
Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings
Sep 27, 2022
Tarsus Submits New Drug Application to the FDA for TP-03 for the Treatment of Demodex Blepharitis
Sep 07, 2022
Tarsus Reports Second Quarter 2022 Financial Results and Recent Business Achievements
Aug 11, 2022
Tarsus Initiates Phase 2a Ersa Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease
Aug 05, 2022
Tarsus to Present at the Jefferies 2022 Healthcare Conference
May 27, 2022
Tarsus Reports First Quarter 2022 Financial Results and Recent Business Achievements
May 10, 2022
Tarsus to Present at Bank of America 2022 Healthcare Conference
May 06, 2022
Tarsus Presents New Findings from Two Studies Demonstrating the Impact of Demodex Blepharitis at the ARVO 2022 Annual Meeting
May 05, 2022
Tarsus Announces Pricing of Upsized $75.6 Million Underwritten Public Offering of Common Stock
May 03, 2022

Presentations